Ask Your Doctor About Traditional Chinese Medicine for Acid Reflux and Heartburn

Many patients experiencing frequent heartburn or acid reflux seek over-the-counter herbal remedies, often asking about traditional Chinese patent medicines for symptom relief. While some herbal formulations—such as those containing Coptis chinensis (Huang Lian), Scutellaria baicalensis (Huang Qin), or Pinellia ternata (Ban Xia)—are historically used in Traditional Chinese Medicine (TCM) to address “stomach fire” or “damp-heat” patterns associated with upper gastrointestinal discomfort, robust clinical evidence supporting their efficacy and safety for gastroesophageal reflux disease (GERD) remains limited.

Current international guidelines—including those from the American College of Gastroenterology and the European Society of Neurogastroenterology and Motility—recommend proton pump inhibitors (PPIs) as first-line pharmacotherapy for moderate-to-severe GERD, with H2-receptor antagonists and antacids serving as adjunctive or short-term options. Herbal preparations are not endorsed as monotherapy for confirmed GERD, erosive esophagitis, or Barrett’s esophagus due to insufficient data on symptom control, mucosal healing, and long-term safety profiles.

Patients considering TCM-based products should consult a licensed healthcare provider before use—particularly if taking concurrent medications, as herb–drug interactions (e.g., altered cytochrome P450 metabolism or additive gastric irritation) may occur. Additionally, unregulated herbal products carry risks of adulteration, heavy metal contamination, or inconsistent dosing. Persistent or worsening symptoms—including dysphagia, unintentional weight loss, hematemesis, or nocturnal awakening—warrant prompt endoscopic evaluation to rule out serious underlying pathology.

Evidence-informed management of chronic heartburn emphasizes lifestyle modification (e.g., weight optimization, meal timing, avoidance of trigger foods), pharmacologic therapy aligned with diagnosis severity, and timely referral when red-flag symptoms emerge. Integrative approaches may have a role in select cases—but only under interdisciplinary supervision and with transparent, patient-centered shared decision-making.